Intrinsic Value

Nabriva Therapeutics plc (NBRV)

$1.42

+0.01 (+0.71%)

Enterprise Value -698,597.67
Net Debt -7.19
Equity Value -698,590.48
Shares Outstanding 2.68
Equity Value Per Share -260,476.81



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt